ID: ALA35920

Max Phase: Preclinical

Molecular Formula: C12H13NO4S

Molecular Weight: 267.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C2=N[C@@](C)(C(=O)O)CS2)c(O)c1

Standard InChI:  InChI=1S/C12H13NO4S/c1-12(11(15)16)6-18-10(13-12)8-4-3-7(17-2)5-9(8)14/h3-5,14H,6H2,1-2H3,(H,15,16)/t12-/m1/s1

Standard InChI Key:  QXLSXGGAQGTCSP-GFCCVEGCSA-N

Associated Targets(non-human)

Monkey 844 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Sapajus apella 176 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 10718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 267.31Molecular Weight (Monoisotopic): 267.0565AlogP: 1.74#Rotatable Bonds: 3
Polar Surface Area: 79.12Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.08CX Basic pKa: 0.58CX LogP: 2.65CX LogD: -0.82
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: 0.58

References

1. Bergeron RJ, Wiegand J, McManis JS, Bussenius J, Smith RE, Weimar WR..  (2003)  Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency.,  46  (8): [PMID:12672247] [10.1021/jm020412d]
2. Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Park JH, Eiler-McManis E, Bergeron J, Brittenham GM..  (2005)  Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.,  48  (3): [PMID:15689166] [10.1021/jm049306x]
3. Bergeron RJ, Wiegand J, McManis JS, Vinson JR, Yao H, Bharti N, Rocca JR..  (2006)  (S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity.,  49  (9): [PMID:16640338] [10.1021/jm0508944]
4. Bergeron RJ, Wiegand J, McManis JS, Bharti N..  (2006)  The design, synthesis, and evaluation of organ-specific iron chelators.,  49  (24): [PMID:17125256] [10.1021/jm0608816]
5. Bergeron RJ, Bharti N, McManis JS, Wiegand J..  (2015)  Metabolically programmed iron chelators.,  23  (17): [PMID:26231739] [10.1016/j.bmc.2015.06.059]

Source